Medical Devices Investors & VC Firms in Europe
650 firms in this list, with a median first check of $540K. 164 of them lead rounds. Generated from verified public data and updated continuously.
Ananda Impact Ventures
MunichPre-Seed–Series B$540K – $3.2M
17 people
TechVision Fonds
AachenPre-Seed–Series A$540K – $2.2M
20 people
MIG Capital AG
MunichSeed–Series C$1.1M – $10.8M
28 people
Agilitas Private Equity
LondonGrowth
29 people
Indaco Venture Partners
MilanSeed
19 people
Beyond Capital Partners
Frankfurt am MainGrowth
25 people
ZEISS Ventures
OberkochenPre-Seed–Series A$550K – $5.5M
22 people
BONVENTURE
MünchenSeed–Series B$1.1M – $2.7M
21 people
Brightlands Venture Partners
GeleenSeed–Series B$540K – $2.2M
14 people
VI Partners
AltendorfSeed–Series A$2.2M – $4.5M
16 people
imec.xpand
LeuvenSeed–Series A$270K – $5.4M
14 people
Inkef
AmsterdamSeed–Series C
12 people
Gateway Trustee GmbH
ViennaPre-Seed–Seed$11K
15 people
Balnord Sp. z o.o.
LuxembourgPre-Seed–Seed$550K – $3.3M
14 people
Oxford Technology Management
Henley-on-ThamesPre-Seed–Series A$200K – $400K
5 people
Sarsia Management AS
BergenSeed–Series A$190K – $475K
14 people
RSJ Investments SICAV a.s.
PrahaPre-Seed–Growth
28 people
Enterprise Investors Sp. z o. o.
WarsawSeries B–Growth$21.6M – $81M
27 people
Innovacom
ParisSeed–Late Stage$540K – $10.8M
17 people
BioMedPartners
BaselSeed–Late Stage$648K – $6.5M
21 people
AdBio partners
ParisSeed–Series A
21 people
MVM Life Science Partners
LondonSeed–Late Stage$20M – $100M
20 people
Asabys Partners
BarcelonaSeed–Growth
18 people
kineo finance
BaselGrowth
22 people
Related lists
Investors & VC Firms in North America (13488)Investors & VC Firms in United States (12527)Investors & VC Firms in Europe (5831)Investors & VC Firms in Global (4707)AI & Machine Learning Investors & VC Firms (4538)Fintech Investors & VC Firms (4530)SaaS Investors & VC Firms (4205)Healthtech Investors & VC Firms (4177)Enterprise Software Investors & VC Firms (4092)Crypto & Web3 Investors & VC Firms (3961)
Data sourced from public filings and firms' own websites — see our methodology.












































































































